High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease

Neuroscience Letters

Volumn 342, Issue 1-2, 2003, Pages 13-16

  Parsons, Richard B ^a   Smith, Stuart W ^a   Waring, Rosemary H ^b   Williams, Adrian C ^c   Ramsden, David B ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Cerebella; Complex I; Neurodegeneration; Nicotinamide adenine dinucleotide; Nicotinamide N methyltransferase; Parkinson's disease

Indexed keywords

BETA CARBOLINE DERIVATIVE; NICOTINAMIDE METHYLTRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TETRAHYDROISOQUINOLINE DERIVATIVE;

ANALYTICAL ERROR; ARTICLE; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; NONPARAMETRIC TEST; PARAMETRIC TEST; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RANK SUM TEST; STUDENT T TEST; TISSUE DISTRIBUTION;

EID: 0037448075     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00218-0     Document Type: Article

References (20)

1. Akoyama K., Matsubara K., Kondo M., Murakawa Y., Suno M., Yamashita K., Yamaguchi S., Kobayashi S. Nicotinamide N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease. Neurosci. Lett. 298:2001;78-80.
2. Bates T.E., Heales S., Davies S.E.C., Boakye P., Clark J.B. Effects of 1-methyl-4-phenylpyridinium on isolated rat-brain mitochondria - evidence for a primary involvement of energy depletion. J. Neurochem. 63:1994;640-648.
3. Fall P.A., Fredrikson M., Axelson O., Granerus A.K. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov. Disord. 14:1999;28-37.
4. Gerlach M., Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J. Neural. Transm. 103:1996;987-1041.
5. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608.
6. Klaidman L.K., Mukherjee S.K., Adams J.D. Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim. Biophys. Acta. 1525:2001;136-148.
7. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
8. Lehr H.-A., van der Loos C.M., Teeling P., Gown A.M. Complete chromogenic separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J. Histochem. Cytochem. 47:1999;119-125.
9. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M.J., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P.J., Wilkinson K.D., Polymeropoulos M.H. The ubiquitin pathway in Parkinson's disease. Nature. 395:1998;451-452.
10. Mizuguchi M., Otsuka N., Sato M., Ishii Y., Kon S., Yamada M., Nishina H., Katada T., Ikeda K. Neuronal localisation of CD38 antigen in the human brain. Brain Res. 697:1995;235-240.
11. Naoi M., Dostert P., Yoshida M., Nagatsu T. N-Methylated tetrahydroisoquinolines as dopaminergic neurotoxins. Adv. Neurol. 60:1993;212-217.
12. Parsons R.B., Smith M.-L., Williams A.C., Waring R.H., Ramsden D.B. Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain. J. Neuropathol. Exp. Neurol. 61:2002;111-124.
13. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
14. Ramsden D.B., Parsons R.B., Ho S.L., Waring R.H. The aetiology of idiopathic Parkinson's disease. J. Clin. Pathol. Mol. Pathol. 54:2001;369-380.
15. Schapira A.H. Mitochondrial Complex I deficiency in Parkinson's disease. Adv. Neurol. 60:1993;288-291.
16. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54:1990;823-827.
17. Smith M.-L., Burnett D., Bennett P., Waring R.H., Brown H.M., Williams A.C., Ramsden D.B. A direct correlation between nicotinamide N-methyltransferase activity and protein levels in the human liver cytosol. Biochim. Biophys. Acta. 1422:1998;238-244.
18. Spector R. Niacin and niacinamide transport in the central nervous system. In vivo studies. J. Neurochem. 33:1979;895-904.
19. Wan F.J., Lin H.C., Kang B.H., Tseng C.J., Tung C.S. D-Amphetamine-induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment. Brain Res. Bull. 50:1999;167-171.
20. Williams A.C., Smith M.-L., Waring R.H., Ramsden D.B. The aetiology of idiopathic Parkinson's disease: a genetic and environmental model. Adv. Neurol. 80:1999;215-218.